Assessment of implantable drug delivery technology: poly (3-hydroxybutyrate) / polypropylene glycol films containing simvastatin

Detalhes bibliográficos
Autor(a) principal: Dourado,Lays Fernanda Nunes
Data de Publicação: 2021
Outros Autores: Pierucci,Amauri, Roa,Juan Pedro Bretas, Carvalho Júnior,Álvaro Dutra de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Matéria (Rio de Janeiro. Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-70762021000400329
Resumo: ABSTRACT Natural polymers have attracted much attention in recent years for the study of new drug delivery systems. These materials are used as polymer matrices to protect the active drug from degradation in the biological environment and to improve the release kinetics of the drug. The poly(3-hydroxybutyrate) (PHB) is a natural biocompatible polymer, widely used in combination with other polymers to improve their physicochemical properties. Thus, this work aimed to develop and characterize films of PHB and blends containing polypropylene glycol (PPG) with different concentrations of simvastatin (Simv.). The films were prepared by casting, dissolving PHB or a blend of PHB / PPG (90:10) and (5% or 25 %) Simv. in chloroform (2% w/v). The solutions were stirred for 3 h and then transferred to an appropriate glass mold for solvent evaporation for 48 h at room temperature. The obtained films were characterized by Fourier Transform Infrared (FTIR) spectroscopy, thermogravimetric analysis, scanning electron microscopy (SEM), optical microscopy, in vitro degradation study, and in vivo biocompatibility test. The results showed that PHB and blends of PHB / PPG are able to form a homogeneous film with the drug inside. A great amount of drug lead to the instability of polymeric matrixes and resulted in a facilitated film degradation. On the other hand, devices with 5% of Simv. were more stable, which suggests the application of these films for biomedical devices. In vivo studies revealed that the films can interact with the animals' organism, and do not undergo rejection. Hence, these films hold an innovative alternative in tissue engineering to promotes drug release by diffusion and erosion of the polymeric material.
id RLAM-1_fd5449d12e457786c199f05c7467677b
oai_identifier_str oai:scielo:S1517-70762021000400329
network_acronym_str RLAM-1
network_name_str Matéria (Rio de Janeiro. Online)
repository_id_str
spelling Assessment of implantable drug delivery technology: poly (3-hydroxybutyrate) / polypropylene glycol films containing simvastatinPolymeric scaffoldsTissue engineeringBiofunctional materialsBiocompatibilityABSTRACT Natural polymers have attracted much attention in recent years for the study of new drug delivery systems. These materials are used as polymer matrices to protect the active drug from degradation in the biological environment and to improve the release kinetics of the drug. The poly(3-hydroxybutyrate) (PHB) is a natural biocompatible polymer, widely used in combination with other polymers to improve their physicochemical properties. Thus, this work aimed to develop and characterize films of PHB and blends containing polypropylene glycol (PPG) with different concentrations of simvastatin (Simv.). The films were prepared by casting, dissolving PHB or a blend of PHB / PPG (90:10) and (5% or 25 %) Simv. in chloroform (2% w/v). The solutions were stirred for 3 h and then transferred to an appropriate glass mold for solvent evaporation for 48 h at room temperature. The obtained films were characterized by Fourier Transform Infrared (FTIR) spectroscopy, thermogravimetric analysis, scanning electron microscopy (SEM), optical microscopy, in vitro degradation study, and in vivo biocompatibility test. The results showed that PHB and blends of PHB / PPG are able to form a homogeneous film with the drug inside. A great amount of drug lead to the instability of polymeric matrixes and resulted in a facilitated film degradation. On the other hand, devices with 5% of Simv. were more stable, which suggests the application of these films for biomedical devices. In vivo studies revealed that the films can interact with the animals' organism, and do not undergo rejection. Hence, these films hold an innovative alternative in tissue engineering to promotes drug release by diffusion and erosion of the polymeric material.Laboratório de Hidrogênio, Coppe - Universidade Federal do Rio de Janeiroem cooperação com a Associação Brasileira do Hidrogênio, ABH22021-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-70762021000400329Matéria (Rio de Janeiro) v.26 n.4 2021reponame:Matéria (Rio de Janeiro. Online)instname:Matéria (Rio de Janeiro. Online)instacron:RLAM10.1590/s1517-707620210004.1389info:eu-repo/semantics/openAccessDourado,Lays Fernanda NunesPierucci,AmauriRoa,Juan Pedro BretasCarvalho Júnior,Álvaro Dutra deeng2021-12-20T00:00:00Zoai:scielo:S1517-70762021000400329Revistahttp://www.materia.coppe.ufrj.br/https://old.scielo.br/oai/scielo-oai.php||materia@labh2.coppe.ufrj.br1517-70761517-7076opendoar:2021-12-20T00:00Matéria (Rio de Janeiro. Online) - Matéria (Rio de Janeiro. Online)false
dc.title.none.fl_str_mv Assessment of implantable drug delivery technology: poly (3-hydroxybutyrate) / polypropylene glycol films containing simvastatin
title Assessment of implantable drug delivery technology: poly (3-hydroxybutyrate) / polypropylene glycol films containing simvastatin
spellingShingle Assessment of implantable drug delivery technology: poly (3-hydroxybutyrate) / polypropylene glycol films containing simvastatin
Dourado,Lays Fernanda Nunes
Polymeric scaffolds
Tissue engineering
Biofunctional materials
Biocompatibility
title_short Assessment of implantable drug delivery technology: poly (3-hydroxybutyrate) / polypropylene glycol films containing simvastatin
title_full Assessment of implantable drug delivery technology: poly (3-hydroxybutyrate) / polypropylene glycol films containing simvastatin
title_fullStr Assessment of implantable drug delivery technology: poly (3-hydroxybutyrate) / polypropylene glycol films containing simvastatin
title_full_unstemmed Assessment of implantable drug delivery technology: poly (3-hydroxybutyrate) / polypropylene glycol films containing simvastatin
title_sort Assessment of implantable drug delivery technology: poly (3-hydroxybutyrate) / polypropylene glycol films containing simvastatin
author Dourado,Lays Fernanda Nunes
author_facet Dourado,Lays Fernanda Nunes
Pierucci,Amauri
Roa,Juan Pedro Bretas
Carvalho Júnior,Álvaro Dutra de
author_role author
author2 Pierucci,Amauri
Roa,Juan Pedro Bretas
Carvalho Júnior,Álvaro Dutra de
author2_role author
author
author
dc.contributor.author.fl_str_mv Dourado,Lays Fernanda Nunes
Pierucci,Amauri
Roa,Juan Pedro Bretas
Carvalho Júnior,Álvaro Dutra de
dc.subject.por.fl_str_mv Polymeric scaffolds
Tissue engineering
Biofunctional materials
Biocompatibility
topic Polymeric scaffolds
Tissue engineering
Biofunctional materials
Biocompatibility
description ABSTRACT Natural polymers have attracted much attention in recent years for the study of new drug delivery systems. These materials are used as polymer matrices to protect the active drug from degradation in the biological environment and to improve the release kinetics of the drug. The poly(3-hydroxybutyrate) (PHB) is a natural biocompatible polymer, widely used in combination with other polymers to improve their physicochemical properties. Thus, this work aimed to develop and characterize films of PHB and blends containing polypropylene glycol (PPG) with different concentrations of simvastatin (Simv.). The films were prepared by casting, dissolving PHB or a blend of PHB / PPG (90:10) and (5% or 25 %) Simv. in chloroform (2% w/v). The solutions were stirred for 3 h and then transferred to an appropriate glass mold for solvent evaporation for 48 h at room temperature. The obtained films were characterized by Fourier Transform Infrared (FTIR) spectroscopy, thermogravimetric analysis, scanning electron microscopy (SEM), optical microscopy, in vitro degradation study, and in vivo biocompatibility test. The results showed that PHB and blends of PHB / PPG are able to form a homogeneous film with the drug inside. A great amount of drug lead to the instability of polymeric matrixes and resulted in a facilitated film degradation. On the other hand, devices with 5% of Simv. were more stable, which suggests the application of these films for biomedical devices. In vivo studies revealed that the films can interact with the animals' organism, and do not undergo rejection. Hence, these films hold an innovative alternative in tissue engineering to promotes drug release by diffusion and erosion of the polymeric material.
publishDate 2021
dc.date.none.fl_str_mv 2021-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-70762021000400329
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-70762021000400329
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/s1517-707620210004.1389
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Laboratório de Hidrogênio, Coppe - Universidade Federal do Rio de Janeiro
em cooperação com a Associação Brasileira do Hidrogênio, ABH2
publisher.none.fl_str_mv Laboratório de Hidrogênio, Coppe - Universidade Federal do Rio de Janeiro
em cooperação com a Associação Brasileira do Hidrogênio, ABH2
dc.source.none.fl_str_mv Matéria (Rio de Janeiro) v.26 n.4 2021
reponame:Matéria (Rio de Janeiro. Online)
instname:Matéria (Rio de Janeiro. Online)
instacron:RLAM
instname_str Matéria (Rio de Janeiro. Online)
instacron_str RLAM
institution RLAM
reponame_str Matéria (Rio de Janeiro. Online)
collection Matéria (Rio de Janeiro. Online)
repository.name.fl_str_mv Matéria (Rio de Janeiro. Online) - Matéria (Rio de Janeiro. Online)
repository.mail.fl_str_mv ||materia@labh2.coppe.ufrj.br
_version_ 1752126694712410112